KDR and breast cancer: We found that VEGFR2 blockade inhibited cancer cell proliferation of the two breast cancer cell lines, MCF-7 and MDA-MB-231, and that the inhibition was achieved by enhancing mitochondrial transcription factor A (TFAM) expression and mitochondrial biogenesis.